These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8935266)

  • 1. Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
    Agarwal BR; Gulvady A; Joshi K; Khemani S; Currimbhoy ZE
    Indian Pediatr; 1995 Sep; 32(9):1002-4. PubMed ID: 8935266
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia.
    Benelux CML Study Group
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S19-20. PubMed ID: 8769694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myeloid leukemia. What's in the future therapy in Black Africa?].
    Dokekias AE; Malanda F; Mbalawa ChG
    Tunis Med; 2003 Mar; 81(3):172-9. PubMed ID: 12793067
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL; Granados E; Peñarrubia MJ
    Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
    Sarasombath P; Sumida K; Kaku DA
    Hawaii Med J; 2002 Mar; 61(3):48, 57. PubMed ID: 11965836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
    Al Bahar S; Pandita R; Nath SV
    Int J Gynaecol Obstet; 2004 Jun; 85(3):281-2. PubMed ID: 15145269
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.
    Patel T; Roychowdhury DF
    N Engl J Med; 1997 Nov; 337(22):1634-5. PubMed ID: 9411231
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
    Guilhot F; Chastang C; Michallet M; Guerci A; Harousseau JL; Maloisel F; Bouabdallah R; Guyotat D; Cheron N; Nicolini F; Abgrall JF; Tanzer J
    N Engl J Med; 1997 Jul; 337(4):223-9. PubMed ID: 9227927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
    Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
    Quintás-Cardama A; Verstovsek S
    Leuk Lymphoma; 2007 Mar; 48(3):445-6. PubMed ID: 17454579
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

  • 12. The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia.
    Talpaz M; Kantarjian HM; O'Brien S; Kurzrock R
    Baillieres Clin Haematol; 1997 Jun; 10(2):291-305. PubMed ID: 9376665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
    Müller MC; Gattermann N; Lahaye T; Deininger MW; Berndt A; Fruehauf S; Neubauer A; Fischer T; Hossfeld DK; Schneller F; Krause SW; Nerl C; Sayer HG; Ottmann OG; Waller C; Aulitzky W; le Coutre P; Freund M; Merx K; Paschka P; König H; Kreil S; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Dec; 17(12):2392-400. PubMed ID: 14523462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.
    Guilhot F; Lacotte-Thierry L
    Hematol Cell Ther; 1998 Oct; 40(5):237-9. PubMed ID: 9844819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Nau JY
    Rev Med Suisse; 2017 Feb; 13(549):386-387. PubMed ID: 28708364
    [No Abstract]   [Full Text] [Related]  

  • 18. Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.
    Creutzig A; Freund M; Caspary L; Alexander K
    Microvasc Res; 1996 Nov; 52(3):288-92. PubMed ID: 8954870
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
    Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B
    Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.